You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Efficient cFS-based On-board Lamberts Solution for DSMs
SBC: ADVANCED SPACE LLC Topic: T11Distributed Spacecraft Missions (DSM) architectures provide unique scientific and programmatic benefits including multipoint in-situ measurements, multi-angle viewpoints, and improved understanding of the connections between separately measured phenomena and their time variations. However, these missions impose significant operational demands on ground tracking resources and mission operators alik ...
STTR Phase II 2019 National Aeronautics and Space Administration -
Power Balance Solver Enhanced by an Experimental Absorption Cross-Section Database
SBC: Electro Magnetic Applications, Inc. Topic: T5We propose the development of a user-friendly software tool for estimating the electric field distributions within spacecraft enclosures based on the Power Balance (PwB) method and enhanced by a database of experimentally determined Absorption Cross-Sections (ACS) of common equipment, components and cables.The software will be built around an already developed PwB solver that determines the statis ...
STTR Phase I 2019 National Aeronautics and Space Administration -
Energy and Velocity Analyzer for Distributions of Electric Rockets
SBC: PLASMA CONTROLS, LLC Topic: T2Plasma Controls, LLC (SBC) and Colorado State University (RI) will mature an energy and species plasma diagnostic for use with plasma thrusters. The combined Energy and Velocity Analyzer for Distributions of Electric Rockets, or the lsquo;E-VADERrsquo;, is needed especially for characterizing the plasma plume of Hall thrusters, where researchers desire to know ion energies and charged species frac ...
STTR Phase I 2019 National Aeronautics and Space Administration -
Braided Thin-Ply Tapes
SBC: OPTERUS RESEARCH AND DEVELOPMENT, INC Topic: T12Opterus proposes to develop braided thin ply composite tapes. The tapes will be braided from ultra-thin spread-tow unidirectional carbon and glass ribbons and will enable a new source and form factor for thin-ply textiles. The resulting tapes will be especially useful for thin high strain composite space deployable structures where they will allow bias plies in long parts without requiring seams. ...
STTR Phase I 2019 National Aeronautics and Space Administration -
Hierarchical Metasurface Optics for Multiplexed Visible to Terahertz Cross-Band Systems
SBC: Rochester Precision Optics, LLC Topic: T8The aim of the proposed program is to design metasurface structures to manipulate electromagnetic waves of extremelynbsp;different frequencies, from visible light to THz.
STTR Phase I 2019 National Aeronautics and Space Administration -
Correction of Splicing Defects in Cystic Fibrosis with Peptide-Oligonucleotide Conjugates and Small Molecule Enhancing Compounds
SBC: Initos Pharmaceuticals LLC Topic: NCATSABSTRACT The pathogenesis of Cystic FibrosisCFis caused by mutations in the gene for CFTRa cAMP activated chloride channel that regulates salt and water transport in epithelial tissuesespecially those in the airwaysRecent progress has resulted in small molecule therapeutic agents that partially correct defects in the CFTR protein due to certain mutationsHoweverin a substantial fraction of CF patie ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of a predictive moderate throughput assay to screen novel Designer Proline-rich antimicrobial peptide Chaperone protein inhibitors (DPCs) against multi-drug resistant pathogen
SBC: Arrevus, Inc. Topic: NIAIDMulti drug resistantMDRbacterial infections represent a significant threat to public healthIt is estimated that the impact of antibiotic resistance will continue to grow resulting in a global economic burden of $trillion and causingmillion deaths annuallyMany of the therapeutics currently under development represent traditional antibiotic approaches or next generation antibiotics that will likely ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Novel and potent SHIP1 inhibitors for improving hematologic recovery following myelosuppressive therapies
SBC: Alterna Therapeutics, Inc. Topic: NHLBIABSTRACT Despite recent advances in targeting cancer cellschemotherapy remains a mainstay of oncologyextending survival and providing cures for many types of cancerHoweverchemotherapy that ablates or suppresses bone marrow cells can be debilitating even when combined with autologous hematopoietic stem cell transplantationHSCTThe treatment causes severe side effects such as anemianeutropenia and th ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Automated CRISPR Screening Using the CellRaft Technology
SBC: CELL MICROSYSTEMS INC Topic: 400Project SummaryGenome wide functional genetics has been recently made possible by pooled library based CRISPR Casgene editing technologyBy randomly knocking out thousands of geneslarge scale screens can be conducted for functional geneticsdrug sensitivity and other phenotypesCurrently howeverthis forward genetic approach is largely relegated to live dead screens in mammalian cellsImproving the sop ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Developing a Small Peptide to Control Autoimmune Inflammation In Type 1 Diabetes
SBC: Op-T-Mune, Inc Topic: NIAIDType 1 Diabetes (T1D) affects an ever growing population. While this disease typically has been associated with juveniles, the disease in adult populations is rapidly increasing. The defining clinical component is insulin loss, which occurs because of sustained inflammation in the islets. At present there is no means to prevent or reverse insulin loss. A major inflammatory pathway in T1D that cont ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health